FEZF1 and neoplasm: The results showed that the tumor growth was dramatically slower in the mice of the sh-FEZF1-AS1-SGC7901 group compared to the sh-NC-SGC7901 group, as evidenced by the reduction of tumor volume (Figures 6A,B).